form8k.htm
Standard
Industrial Classification Code 3826
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15 (D)
of
the
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): March 19, 2009
Arrayit
Corporation
(Formerly
Integrated Media Holdings, Inc.)
(Exact
name of registrant as specified in its charter)
NEVADA
(State or
other jurisdiction of incorporation or organization)
33-119586
|
76-0600966
|
(Commission File
Number)
|
(IRS Employer Identification
Number)
|
524 East
Weddell Drive
Sunnyvale,
CA 94089
(Address
of principal executive offices)
Rene
Schena
524 East
Weddell Drive
Sunnyvale,
CA 94089
(Name and
address of agent for service)
408-744-1711
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Effective Thursday, March 19, 2009, the final steps of the business combination
with Integrated Media Holdings, Inc. has been completed and the Company’s common
stock will begin trading on the OTC Bulletin Boards as “ARYC”. In addition, the
company name has changed, has reincorporated to Nevada from Delaware, and
reverse split its common stock and Series A Convertible Preferred stock in the
ratio of one for thirty shares.
ITEM
9.01 – Financial Statements and Exhibits
Press
Release
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
Arrayit
Corporation
|
|
|
|
|
|
|
Date: March
19, 2009
|
By:
/s/ Rene A.
Schena
|
|
Name:
Rene A. Schena
Title:
Chief Executive Officer
|
|
Exhibit
9.01
ARRAYIT
CORPORATION TRADING UNDER NEW SYMBOL “ARYC”
Sunnyvale,
CA—Arrayit Corporation (OTC BB: ARYC), a leader of proprietary life science
technologies founded on the Company’s vast microarray technology products,
announced today that the final steps of the business combination with Integrated
Media Holdings, Inc. has been completed, and thus will begin trading on the OTC
Bulletin Boards as “ARYC” effective Thursday, March 19, 2009.
“This
symbol approval concludes a long process of going public, and we are very
pleased to have completed the final step in our move to enter the public arena
and prepare to obtain capital for rapid expansion of our existing product line.
With ARYC as our new ticker symbol, we can now better leverage our Company’s
intellectual properties in the public markets to further Arrayit’s business
objectives,” stated Ms. Rene Schena, Chief Executive Officer. “Our move from
being privately held to a publicly held company has also resulted in us
re-domiciling, as well as completing a reverse split of our common stock,” she
continued.
Arrayit
Corporation, formerly Integrated Media Holdings, Inc., has completed approval to
change the name of the entity, re-domiciling to Nevada from Delaware, and
completing a reverse stock split of one for 30 shares.
About
Arrayit Corporation
Arrayit
Corporation, headquartered in Sunnyvale, California, leads and empowers the
genetic, research, pharmaceutical, and diagnostic communities through the
discovery, development and manufacture of proprietary life science technologies
and consumables for disease prevention, treatment and cure. It now offers over
650 products to a customer base of more than 2,500 laboratories worldwide,
including most every major university, pharmaceutical and biotech company, major
agricultural and chemical company, government agency, national research
foundation and many private sector enterprises. Please visit www.arrayit.com for
more information.
Safe
Harbor Statement
Except
for historical information contained herein, statements made in this release
that would constitute forward-looking statements may involve certain risks and
uncertainties. All forward-looking statements made in this release are based on
currently available information and the Company assumes no responsibility to
update any such forward-looking statement. The following factors, among others,
may cause actual results to differ materially from the results suggested in the
forward-looking statements. The factors include, but are not limited to, risks
that may result from changes in the Company's business operations; our ability
to keep pace with technological advances; significant competition in the
biomedical business; our relationships with key suppliers and customers; quality
and consumer acceptance of newly introduced products; market volatility;
non-availability of product; excess inventory; price and product competition;
new product introductions, the outcome of our legal disputes; the possibility
that the review of our prior filings by the SEC may result in changes to our
financial statements; and the possibility that stockholders or regulatory
authorities may initiate proceedings against Arrayit and/or our officers and
directors as a result of any restatements. Risk factors associated with our
business, including some of the facts set forth herein, are detailed in the
Company's Form 10-K for the fiscal year ended December 31, 2007 and Form 10-Q/A
for the fiscal first quarter ended March 31, 2008 and Form 10-Q for the fiscal
second quarter ended June 30, 2008.
Contact:
Arrayit
Corporation
Email: investorinfo@arrayit.com
Website: http://www.arrayit.com